De rapporterede bivirkninger er i overensstemmelse med de for andre hLH indeholdende produkter rapporterede, bortset fra reaktioner på injektionsstedet, hvor hyppigheden er signifikant lavere ved Luveris behandling.
The reported undesirable effects are in agreement with those reported for other hLH-containing medicinal products, except for injection site reactions where the incidence was significantly lower with Luveris treatment.